Northern Trust
EXAS

Northern Trust’s Exact Sciences EXAS Stock Holding History

Northern Trust’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,091,519
Closed -$111M – 4444
2025
Q4 		$111M Sell
1,091,519
-17,895
-2% -$1.44M 0.01% 694
2025
Q3 		$60.7M Sell
1,109,414
-4,185
-0.4% -$209K 0.01% 1011
2025
Q2 		$59.2M Sell
1,113,599
-23,330
-2% -$1.19M 0.01% 992
2025
Q1 		$49.2M Sell
1,136,929
-10,342
-0.9% -$524K 0.01% 1092
2024
Q4 		$64.5M Buy
1,147,271
+264,430
+30% +$16.5M 0.01% 977
2024
Q3 		$60.1M Sell
882,841
-155,584
-15% -$8.78M 0.01% 912
2024
Q2 		$43.9M Buy
1,038,425
+49,214
+5% +$2.71M 0.01% 1080
2024
Q1 		$68.3M Sell
989,211
-92,295
-9% -$5.84M 0.01% 802
2023
Q4 		$80M Sell
1,081,506
-46,870
-4% -$3.07M 0.01% 711
2023
Q3 		$77M Buy
1,128,376
+57,423
+5% +$4.87M 0.01% 695
2023
Q2 		$101M Sell
1,070,953
-10,862
-1% -$847K 0.02% 595
2023
Q1 		$73.4M Buy
1,081,815
+16,561
+2% +$1.06M 0.01% 724
2022
Q4 		$52.7M Sell
1,065,254
-12,651
-1% -$517K 0.01% 897
2022
Q3 		$35M Buy
1,077,905
+27,795
+3% +$1.15M 0.01% 1088
2022
Q2 		$41.4M Sell
1,050,110
-48,877
-4% -$2.61M 0.01% 999
2022
Q1 		$76.8M Sell
1,098,987
-358
-0% -$26.2K 0.01% 763
2021
Q4 		$85.6M Sell
1,099,345
-7,104
-0.6% -$627K 0.01% 744
2021
Q3 		$106M Buy
1,106,449
+76,220
+7% +$8.05M 0.02% 633
2021
Q2 		$128M Buy
1,030,229
+40,556
+4% +$4.84M 0.02% 573
2021
Q1 		$130M Buy
989,673
+22,032
+2% +$3.02M 0.02% 565
2020
Q4 		$128M Buy
967,641
+26,630
+3% +$3.22M 0.03% 543
2020
Q3 		$95.9M Sell
941,011
-13,912
-1% -$1.2M 0.02% 577
2020
Q2 		$83M Buy
954,923
+38,983
+4% +$3.11M 0.02% 601
2020
Q1 		$53.1M Buy
915,940
+4,988
+0.5% +$405K 0.02% 743
2019
Q4 		$84.2M Buy
910,952
+84,913
+10% +$7.47M 0.02% 672
2019
Q3 		$74.6M Buy
826,039
+49,143
+6% +$5.6M 0.02% 688
2019
Q2 		$91.7M Buy
776,896
+168,277
+28% +$17M 0.02% 610
2019
Q1 		$52.7M Buy
608,619
+15,403
+3% +$1.31M 0.01% 924
2018
Q4 		$37.4M Sell
593,216
-3,099
-0.5% -$213K 0.01% 1069
2018
Q3 		$47.1M Sell
596,315
-3,655
-0.6% -$238K 0.01% 1075
2018
Q2 		$35.9M Sell
599,970
-879,581
-59% -$47.3M 0.01% 1303
2018
Q1 		$59.7M Buy
1,479,551
+995
+0.1% +$48.5K 0.02% 839
2017
Q4 		$77.7M Sell
1,478,556
-26,482
-2% -$1.41M 0.02% 681
2017
Q3 		$70.9M Buy
1,505,038
+53,209
+4% +$2.14M 0.02% 721
2017
Q2 		$51.4M Buy
1,451,829
+86,747
+6% +$2.68M 0.01% 908
2017
Q1 		$32.2M Buy
1,365,082
+12,428
+0.9% +$246K 0.01% 1274
2016
Q4 		$18.1M Buy
1,352,654
+42,578
+3% +$687K 0.01% 1677
2016
Q3 		$24.3M Buy
1,310,076
+99,269
+8% +$1.75M 0.01% 1427
2016
Q2 		$14.8M Buy
1,210,807
+71,598
+6% +$539K ﹤0.01% 1748
2016
Q1 		$7.75M Sell
1,139,209
-24,262
-2% -$155K ﹤0.01% 2142
2015
Q4 		$10.7M Sell
1,163,471
-6,636
-0.6% -$61.7K ﹤0.01% 1966
2015
Q3 		$21.1M Buy
1,170,107
+126,339
+12% +$2.9M 0.01% 1457
2015
Q2 		$31M Buy
1,043,768
+26,415
+3% +$664K 0.01% 1225
2015
Q1 		$22.4M Buy
1,017,353
+61,386
+6% +$1.56M 0.01% 1491
2014
Q4 		$26.2M Sell
955,967
-12,700
-1% -$309K 0.01% 1329
2014
Q3 		$18.8M Sell
968,667
-41,015
-4% -$752K 0.01% 1556
2014
Q2 		$17.2M Buy
1,009,682
+66,141
+7% +$911K 0.01% 1635
2014
Q1 		$13.4M Sell
943,541
-84,150
-8% -$1.14M ﹤0.01% 1889
2013
Q4 		$12.1M Buy
1,027,691
+25,608
+3% +$294K ﹤0.01% 1947
2013
Q3 		$11.8M Buy
1,002,083
+66,105
+7% +$848K ﹤0.01% 1900
2013
Q2 		$13M Buy
+935,978
New +$10.2M ﹤0.01% 1724

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Northern Trust's EXAS Position: Q1 2026 in Review

Northern Trust sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,091,519 shares — an estimated $111M sold.

Northern Trust first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $130M in Q1 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Northern Trust reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Northern Trust sold 1,091,519 Exact Sciences shares in Q1 2026, an estimated $111M.
  • Northern Trust first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Northern Trust's Exact Sciences position peaked at $130M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.